These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 26289913

  • 1. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.
    Toshimori J, Nouso K, Nakamura S, Wada N, Morimoto Y, Takeuchi Y, Yasunaka T, Kuwaki K, Ohnishi H, Ikeda F, Shiraha H, Takaki A, Yamamoto K.
    Acta Med Okayama; 2015; 69(4):219-26. PubMed ID: 26289913
    [Abstract] [Full Text] [Related]

  • 2. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M, Inoue T, Kudo M, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Minami Y, Ueshima K, Nishida N, Murakami T.
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [Abstract] [Full Text] [Related]

  • 3. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
    Kim JS, Kim W, So YH, Yu SJ, Kim BG.
    J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H.
    J Gastroenterol; 2003 Jan; 38(10):977-81. PubMed ID: 14614605
    [Abstract] [Full Text] [Related]

  • 5. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
    Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH.
    World J Gastroenterol; 2016 Mar 14; 22(10):2993-3005. PubMed ID: 26973395
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar 14; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 7. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS, Rhim H, Cho OK, Koh BH, Kim Y.
    Eur J Radiol; 2006 Sep 14; 59(3):432-41. PubMed ID: 16690240
    [Abstract] [Full Text] [Related]

  • 8. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.
    J Clin Gastroenterol; 2012 Jan 14; 46(1):62-70. PubMed ID: 21934530
    [Abstract] [Full Text] [Related]

  • 9. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Scand J Gastroenterol; 2014 Mar 14; 49(3):373-80. PubMed ID: 24354931
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, Kumada H.
    AJR Am J Roentgenol; 2011 Oct 14; 197(4):W665-73. PubMed ID: 21940538
    [Abstract] [Full Text] [Related]

  • 11. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 14; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.
    J Hepatol; 2019 May 14; 70(5):866-873. PubMed ID: 30615906
    [Abstract] [Full Text] [Related]

  • 13. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
    Hao Y, Numata K, Ishii T, Fukuda H, Maeda S, Nakano M, Tanaka K.
    World J Gastroenterol; 2017 May 07; 23(17):3111-3121. PubMed ID: 28533668
    [Abstract] [Full Text] [Related]

  • 14. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A, Del Prete V, Antonino M, Crucinio N, Neve V, Di Leo A, Carr BI, Barone M.
    Dig Liver Dis; 2014 Nov 07; 46(11):1014-9. PubMed ID: 25085684
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, Honda S, Koshiishi T, Fujimoto T.
    Cardiovasc Intervent Radiol; 2007 Nov 07; 30(4):696-704. PubMed ID: 17497071
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 07; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK.
    Ann Surg Oncol; 2007 Aug 07; 14(8):2319-29. PubMed ID: 17522947
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
    Yang B, Zou J, Xia J, Ren Z, Gan Y, Wang Y, Zhang B, Ge N, Wang D, Chen Y, Chen R, Li L, Ye S, Wang X.
    Eur J Radiol; 2011 Aug 07; 79(2):196-200. PubMed ID: 20303686
    [Abstract] [Full Text] [Related]

  • 19. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M, Yamashita YI, Imai K, Umezaki N, Yamao T, Kaida T, Mima K, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Baba H.
    Anticancer Res; 2018 Feb 07; 38(2):1047-1052. PubMed ID: 29374739
    [Abstract] [Full Text] [Related]

  • 20. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH.
    World J Gastroenterol; 2015 Feb 07; 21(5):1554-66. PubMed ID: 25663774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.